Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 May;109(1):175–177. doi: 10.1111/j.1476-5381.1993.tb13549.x

The effect of lifarizine (RS-87476), a novel sodium and calcium channel modulator, on ischaemic dopamine depletion in the corpus striatum of the gerbil.

C M Brown 1, C Calder 1, B J Alps 1, M Spedding 1
PMCID: PMC2175597  PMID: 8388296

Abstract

1. Unilateral ligation of the right common carotid artery in the anaesthetized gerbil for 3 h caused a 62.7% decrease in ipsilateral dopamine in the corpus striatum from 1.40 (+/- 0.13, n = 27) micrograms g-1 in the non-ischaemic hemisphere to 0.47 (+/- 0.07, n = 27) micrograms g-1 in the ischaemic hemisphere (all results are expressed as mean +/- s.e. mean). In sham-operated animals there were no differences in the dopamine levels (1.31 +/- 0.14 micrograms g-1, n = 11, left; 1.27 +/- 0.13 micrograms g-1, n = 11 in the right hemisphere). Animals with intact communicating arteries in the circulus arteriosus were excluded. 2. Lifarizine (RS-87476; 250, 500, but not 50, micrograms kg-1, i.p.) protected against this dopamine depletion showing only a 9.2% decrease at 250 micrograms kg-1, i.p. (P < 0.01) and no decrease at 500 micrograms kg-1, i.p. (P < 0.01). 3. Nicardipine (250 micrograms kg-1, p.o.) was effective when administered chronically once daily for 10 days (26.6% decrease, P < 0.05) but not when administered acutely at 50 micrograms kg-1, i.p.

Full text

PDF
175

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alps B. J., Calder C., Hass W. K., Wilson A. D. Comparative protective effects of nicardipine, flunarizine, lidoflazine and nimodipine against ischaemic injury in the hippocampus of the Mongolian gerbil. Br J Pharmacol. 1988 Apr;93(4):877–883. doi: 10.1111/j.1476-5381.1988.tb11475.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alps B. J., Hass W. K. The potential beneficial effect of nicardipine in a rat model of transient forebrain ischemia. Neurology. 1987 May;37(5):809–814. doi: 10.1212/wnl.37.5.809. [DOI] [PubMed] [Google Scholar]
  3. Bozzao L., Fantozzi L. M., Bastianello S., Bozzao A., Fieschi C. Early collateral blood supply and late parenchymal brain damage in patients with middle cerebral artery occlusion. Stroke. 1989 Jun;20(6):735–740. doi: 10.1161/01.str.20.6.735. [DOI] [PubMed] [Google Scholar]
  4. Brannan T., Weinberger J., Knott P., Taff I., Kaufmann H., Togasaki D., Nieves-Rosa J., Maker H. Direct evidence of acute, massive striatal dopamine release in gerbils with unilateral strokes. Stroke. 1987 Jan-Feb;18(1):108–110. doi: 10.1161/01.str.18.1.108. [DOI] [PubMed] [Google Scholar]
  5. Caplan L., Babikian V., Helgason C., Hier D. B., DeWitt D., Patel D., Stein R. Occlusive disease of the middle cerebral artery. Neurology. 1985 Jul;35(7):975–982. doi: 10.1212/wnl.35.7.975. [DOI] [PubMed] [Google Scholar]
  6. Eriksson B. M., Persson B. A. Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection. J Chromatogr. 1982 Mar 12;228:143–154. doi: 10.1016/s0378-4347(00)80427-2. [DOI] [PubMed] [Google Scholar]
  7. Grotta J. C., Pettigrew L. C., Lockwood A. H., Reid C., Reich C. Brain extraction of a calcium channel blocker. Ann Neurol. 1987 Feb;21(2):171–175. doi: 10.1002/ana.410210209. [DOI] [PubMed] [Google Scholar]
  8. Grotta J. C., Pettigrew L. C., Rosenbaum D., Reid C., Rhoades H., McCandless D. Efficacy and mechanism of action of a calcium channel blocker after global cerebral ischemia in rats. Stroke. 1988 Apr;19(4):447–454. doi: 10.1161/01.str.19.4.447. [DOI] [PubMed] [Google Scholar]
  9. Hadani M., Young W., Flamm E. S. Nicardipine reduces calcium accumulation and electrolyte derangements in regional cerebral ischemia in rats. Stroke. 1988 Sep;19(9):1125–1132. doi: 10.1161/01.str.19.9.1125. [DOI] [PubMed] [Google Scholar]
  10. Kucharczyk J., Mintorovitch J., Moseley M. E., Asgari H. S., Sevick R. J., Derugin N., Norman D. Ischemic brain damage: reduction by sodium-calcium ion channel modulator RS-87476. Radiology. 1991 Apr;179(1):221–227. doi: 10.1148/radiology.179.1.2006281. [DOI] [PubMed] [Google Scholar]
  11. Miyamoto J., Hisatome I., Matsuoka S., Kosaka H., Kurata Y., Tanaka Y., Nawada T., Kotake H., Mashiba H., Sato R. The effect of TYB-3823, a new antiarrhythmic drug, on sodium current in isolated cardiac cells. Br J Pharmacol. 1991 Sep;104(1):25–30. doi: 10.1111/j.1476-5381.1991.tb12379.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pérez-Pinzón M. A., Rosenthal M., Sick T. J., Lutz P. L., Pablo J., Mash D. Downregulation of sodium channels during anoxia: a putative survival strategy of turtle brain. Am J Physiol. 1992 Apr;262(4 Pt 2):R712–R715. doi: 10.1152/ajpregu.1992.262.4.R712. [DOI] [PubMed] [Google Scholar]
  13. Saito I., Segawa H., Shiokawa Y., Taniguchi M., Tsutsumi K. Middle cerebral artery occlusion: correlation of computed tomography and angiography with clinical outcome. Stroke. 1987 Sep-Oct;18(5):863–868. doi: 10.1161/01.str.18.5.863. [DOI] [PubMed] [Google Scholar]
  14. Siesjö B. K. Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab. 1981;1(2):155–185. doi: 10.1038/jcbfm.1981.18. [DOI] [PubMed] [Google Scholar]
  15. Siesjö B. K. Historical overview. Calcium, ischemia, and death of brain cells. Ann N Y Acad Sci. 1988;522:638–661. doi: 10.1111/j.1749-6632.1988.tb33410.x. [DOI] [PubMed] [Google Scholar]
  16. Spedding M., Kilpatrick A. T., Alps B. J., Speddings M. Activators and inactivators of calcium channels: effects in the central nervous system. Fundam Clin Pharmacol. 1989;3 (Suppl):3s–29s. doi: 10.1111/j.1472-8206.1989.tb00472.x. [DOI] [PubMed] [Google Scholar]
  17. Zervas N. T., Hori H., Negora M., Wurtman R. J., Larin F., Lavyne M. H. Reduction in brain dopamine following experimental cerebral ischaemia. Nature. 1974 Feb 1;247(5439):283–284. doi: 10.1038/247283a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES